Comparing Missing Data Strategies for Generalized Pairwise Comparisons in Randomized Clinical Trials: A Simulation Study
Statistics in Medicine · 2026
DOI: 10.1002/sim.70737 ↗At a glance
Vergleichsstudie in Statistics in Medicine, 2026. Written by Ruben P A van Eijk and 1 co-authors. Institution: Department of Biomedical Data Science and Centre for Innovative Study Designs, School of Medicine, Stanford University, Stanford, California, USA. Major MEDLINE topics: Randomized Controlled Trials as Topic. 41 references. The full text is freely available (open access, CC BY 4.0). Funded by: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, U.S. Department of Defense.
Abstract (original language)
Generalized pairwise comparisons are increasingly being used in randomized clinical trials. This study evaluates how missing data strategies impact the operating characteristics of endpoints combining overall survival and a longitudinal outcome. A simulation study was conducted to evaluate the impact of censoring and missing longitudinal data on the Type I error, power, and bias of a hierarchical composite endpoint. Seven missing data strategies were identified from the literature, including assigning ties to missing patient pairs, comparing patients at their last common visit, and applying multiple imputation. Conditional longitudinal and survival data were generated based on the natural history of amyotrophic lateral sclerosis. Simulation scenarios varied in censoring rates, extent of missing longitudinal data, differential attrition between treatment arms, and the dependency of missingness on disease severity. All methods were unbiased and maintained nominal Type I error when censoring and missingness were balanced across treatment arms. Under imbalance, however, Type I error increased—reaching up to 0.378 for some strategies. The last common visit strategy was the only approach that consistently preserved nominal error rates (0.025 ± 0.002). Regarding statistical power, all methods exhibited a loss of precision and increased bias under the alternative hypothesis as missingness increased. Multiple imputation partially recovered power and reduced bias but inflated the Type I error rate in scenarios with differential attrition. As generalized pairwise comparisons are increasingly used in pivotal clinical trials—and therefore in regulatory contexts—our findings provide practical guidance for selecting a robust primary analysis strategy and minimizing bias arising from incomplete data.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biomedical Data Science and Centre for Innovative Study Designs, School of Medicine, Stanford University, Stanford, California, USA.
- Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
ORCID profiles: Ruben P A van Eijk, Ying Lu
Funding
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- U.S. Department of Defense
Cite
APA
van Eijk, R. P. A., & Lu, Y. (2026). Comparing Missing Data Strategies for Generalized Pairwise Comparisons in Randomized Clinical Trials: A Simulation Study. Statistics in Medicine. https://doi.org/10.1002/sim.70737
Vancouver
van Eijk RPA, Lu Y. Comparing Missing Data Strategies for Generalized Pairwise Comparisons in Randomized Clinical Trials: A Simulation Study. Statistics in Medicine. 2026. doi:10.1002/sim.70737
BibTeX
@article{vanEijk2026,
author = {van Eijk, Ruben P A and Lu, Ying},
title = {Comparing Missing Data Strategies for Generalized Pairwise Comparisons in Randomized Clinical Trials: A Simulation Study},
journal = {Statistics in Medicine},
year = {2026},
doi = {10.1002/sim.70737}
}
EUVIMED